Personal TTFields device guided by imaging for brain tumor
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether using a personalized TTFields device—placed based on imaging—can help treat adults with glioblastoma (GBM) after surgery and radiation. It’s designed for specific GBM genetic types and may help deliver therapy more precisely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (age 22 or older).
- You have confirmed glioblastoma (GBM), or a GBM type based on tumor genetics tests.
- You already had the most complete safe surgery possible, and then standard radiation (about 6 weeks) or a shorter radiation schedule (about 3 weeks).
- Your tumor matches one of the allowed genetic profiles (for example MGMT and/or IDH results).
- You must have blood, liver, and kidney function adequate for treatment and be able to take the maintenance medicine (temozolomide/TMZ) if required.
- You are willing to use TTFields and wear the device as instructed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special form of radiation therapy for older or frail adults with a type of brain tumor called glioma. The radiation is placed directly in the area where the tumor was removed during surgery, which may help prevent the tumor from growing back.
This study tests a new way to plan and deliver radiation therapy for glioblastoma (an aggressive brain tumor) using special MRI scans to target cancer cells more precisely. The goal is to improve treatment effectiveness while reducing harm to healthy brain tissue.
This trial tests a special radiation boost that targets low-oxygen areas of the brain tumor during standard radiation therapy. It may help control the tumor better for people with newly diagnosed or recurrent glioblastoma.
This trial tests whether adding a precise, MRI-guided radiation treatment to tumor-treating electric fields (TTFields) can help people with recurrent glioblastoma. You may qualify if your tumor has come back 1 to 3 times after standard therapy and you haven't had certain prior treatments.
This trial looks at how well Tumor Treating Fields (TTFields) therapy works for people with newly diagnosed glioblastoma. Researchers will study blood and tumor samples to find markers that might predict how well the treatment works.
This trial tests whether customized drug screening on your tumor cells can help doctors choose the best treatment for you. Your tumor cells will be grown in the lab and tested against different drugs to find what works best, combined with short-course radiation therapy.
Hear when a new GBM trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.